Two recent US studies have provided further data on the risk of breast cancer in postmenopausal women receiving hormone replacement therapy (HRT), but they still leave many questions unanswered. Following interviews with 2 of the leading researchers in this discipline,Inpharma® aims to put the latest data into context.